STRAGEN NORDIC A/S: Financial statements 2018
CVR: 26717825
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
STRAGEN NORDIC A/S (CVR 26717825) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 5,489,210 and a net result of DKK 1,883,508 compared with DKK 496,838 the year before. That is an increase of 33.3% compared with the year before. Equity in the 2018 report amounted to DKK 5,368,593. The solvency ratio was 30.8%.
- Gross Profit
- DKK 5,489,210
- Profit/Loss
- DKK 1,883,508
- Equity
- DKK 5,368,593
- Total Assets
- DKK 17,408,472
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 5.5M | 1.9M | 5.4M | - |
| 2017 | - | 4.1M | 497K | 3.5M | - |
| 2016 | - | 4.2M | 702K | 3.3M | - |
| 2015 | - | 3.4M | -261K | 2.6M | - |
| 2014 | - | 4.3M | 171K | 2.8M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
STRAGEN NORDIC A/S has published its annual report for 2017. Gross profit came to DKK 4,116,414, and the net result was DKK 496,838.
About STRAGEN NORDIC A/S
STRAGEN NORDIC A/S is a Danish company of the type Aktieselskab based in Slangerup, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Anne Franch Nyquist-Hansen and Didier Remi Dargent. The board consists of Didier Remi Dargent (chair), Jean-Yves Paul Etienne Desmottes and Ludovic Alonzi. The company is owned by Strategic Generics France. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 4,246,350 and a net result of DKK 529,103 compared with DKK 2,665,035 the year before. Equity in the 2025 report amounted to DKK 9,440,623.
